GSK
Director, Quantitative Systems Pharmacology
$188K–$314K
USA - Pennsylvania - Upper Providence +4 · Hybrid (Remote & On-site) · Director · Full-time · Posted Oct 12, 2026
- Location
- USA - Pennsylvania - Upper Providence
GSK HQ
UK - Hertfordshire - Stevenage
Waltham
Durham Blackwell Street - Experience
- Minimum 7 years; experience in mechanistic mathematical modeling, inverse problem modeling and simulation, and/or scientific machine learning methodologies.
- Education
- PhD, MD, or PharmD.
About the job
Leads quantitative systems pharmacology modeling and strategy to support drug discovery and development in GSK’s Respiratory, Immunology and Inflammation portfolio.
What you'll do
- Build and guide mechanistic QSP and QST models and simulations to understand disease, drug action, and trial design.
- Define and coordinate QSP/QST and clinical pharmacology development strategies, integrating evidence across disease programs.
- Collaborate with cross-functional and external experts, advise leadership, and communicate research through scientific publications.
What they ask for
- PhD, MD, or PharmD, with experience in mechanistic modelling and simulation and systems biology applied to pharmaceutical R&D.
- At least 7 years in mechanistic mathematical modeling, inverse problem modeling and simulation, and/or scientific machine learning applied to preclinical or clinical drug-development questions.
- Experience working with senior stakeholders in a cross-functional environment.
- Track record implementing Model-Informed Drug Discovery and Development (MIDD) approaches.
Nice to have
- Prior experience in Hepatology, Respiratory and/or Cardiometabolic diseases.
- Ability to collaborate effectively, communicate, exercise sound judgment, and adapt priorities in complex situations.
Pay
$188,100 to $313,500 USD annual base salary
Tools
QSP, QST, scientific ML, AIML, inverse-problem modelling, Model-Informed Drug Discovery and Development (MIDD)
AI focus
Use scientific machine learning and AIML alongside mechanistic modeling to improve model development and support drug-development decisions.
Model-written summary · the original posting is authoritative